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Abstract
Background The rational prescribing of drugs is an
essential skill of medical doctors. Clinical pharmacologists
play an important role in the development of these skills by
teaching clinical pharmacology and therapeutics (CP&T) to
undergraduate medical students. Although the approaches
to teaching CP&T have undergone many changes over the
last decennia, it is essential that the actual teaching of
CP&T continues to be a major part of the undergraduate
medical curriculum.
Objectives The learning objectives of CP&T teaching in
terms of developing the therapeutic competencies of
undergraduate medical students are described, with an
emphasis on therapeutic decision-making. On the basis of
current theories of cognitive psychology and medical
education, context-learning is presented as an effective
approach by which to achieve therapeutic competencies. An
example of a CP&T curriculum is presented.
Keywords Clinicalpharmacology&therapeutics.
Education.Pharmacotherapy.Teaching.Undergraduate
Introduction
The field of modern clinical pharmacology began to
develop in the second half of the 19th century when
physicians began to realise that agents such as heavy metals
and plant extracts, then in use, more often made diseases
worse instead of better [1]. In 1969, a study group on
clinical pharmacology was convened by the World Health
Organisation (WHO) in order to demarcate the scope of this
relatively new discipline [2]. They concluded that the tasks
of the clinical pharmacologist include: (1) research into the
action of drugs in humans, (2) services such as providing
information on drugs and (3) teaching clinical pharmacol-
ogy and therapeutics (CP&T) to medical students, hospital
staff and physicians [2]. While both research and services
are important areas of clinical pharmacology, it is in their
roles as teachers of CP&T to medical students that clinical
pharmacologists have an extremely important effect on the
development of rational prescribing by medical doctors.
However, despite this importance, the undergraduate
teaching of CP&T has not, in contrast to the two other
functions of the clinical pharmacologist, achieved an
international level of recognition [3, 4]. The lesser attention
given to teaching CP&T is also reflected in the small
number of scientific publications. For example, only about
20 articles on teaching CP&T were published in the
European Journal of Clinical Pharmacology between
1980 and 2000.
In many medical schools, undergraduate students learn
little about the therapeutic use of drugs and even after
graduation, some doctors read little on the subject and rely
too much on the promotional efforts and information from the
pharmaceutical industry. As indicated by a survey conducted
under the auspices of the WHO in 1989, in European medical
schools, an average of only 28 h was devoted to teaching
clinical pharmacology, even though over 100 h were devoted
to pharmacology [5, 6]. However, the number of hours spent
teaching CP&T is probably underestimated since clinical
pharmacology and particularly therapeutics are taught im-
plicitly during the clinical clerkships.
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e-mail: thpgm.devries@vumc.nlThe European Association of Clinical Pharmacology and
Therapeutics (EACPT) was founded in 1993 to promote the
field of CP&T. One of the important objectives of the
EACPT was to develop CP&T in Europe by improving and
harmonising the teaching of the rational use of drugs at the
undergraduate and postgraduate levels. An Education
Subcommittee of the EACPT was subsequently established
in 1997 to increase the amount of attention given to as well
as the quality of teaching CP&T. The first task of this
subcommittee was to identify the educational requirements
of medical students in terms of CP&T. A positive
consequence of the expanded attention for the teaching of
CP&T has been the substantial increase of scientific
publications on teaching CP&T during the past decade:
there have been about 32 articles published between 2000
and 2007 in the European Journal of Clinical Pharmacol-
ogy, which is twice as many as during the preceding two
decades.
Unfortunately, despite the increasing amount of attention
being given to the teaching of CP&T, CP&T educational
programmes are still not optimal in many medical schools
[7]. Nowadays, many graduates still feel insufficiently
prepared to assume prescription responsibilities after
graduation [7]. Therefore, it is important to improve the
undergraduate teaching in CP&T.
In this review, we shall endeavour to indicate the
essential aspects of teaching CP&T to undergraduate
medical students. To this end, we first describe what is
known about the general learning objectives in CP&T that
medical students should master before graduation. Subse-
quently, we focus on an essential (in our opinion) core
learning objective: ‘therapeutic decision-making’.W eg oo n
to describe how medical students and physicians arrive at a
therapeutic decision and discuss the possibilities of teaching
medical students rational pharmacotherapy. Finally, we
recommend approaches for organising, presenting and
assessing CP&T in the undergraduate medical curriculum.
From core learning objectives to competencies
In many curricula, the teaching in clinical disciplines is
centred on symptoms and diagnosis, and little or no time is
given to the principles of drug treatment. In the past, CP&T
was only taught as short courses in medical schools in
which information was presented in the form of dogmatic
indications of which drug to use and when. In some
medical schools, however, clinical pharmacologists partic-
ipated in basic pharmacology courses, usually given early
in the clinical part of the curriculum [4]. Notwithstanding,
much of the postgraduate and continuing education of the
practicing physician has been left to the persuasive methods
of the pharmaceutical industry [1].
It was only in 1989 that the Council for Medical Student
Education in Clinical Pharmacology and Therapeutics
stressed the importance of defining a core curriculum for
clinical pharmacology in the medical curriculum. One year
later, Nierenberg developed a core curriculum for medical
students in CP&T [9]. Based on consensus between 40
clinical pharmacology teachers, Nierenberg formulated a
list of core knowledge, skills and attitudes that every
medical student should master before graduation in order to
be able to prescribe effectively and safely [8, 9].
Core knowledge in clinical pharmacology deals with the
facts that are necessary to make rational and optimal
therapeutic plans; it includes the principles needed to
organise these facts into useful information and to recognise
when essential facts are missing [5, 8]. Core skills are in
many ways similar to core knowledge because knowledge
must be learned and used as the medical student develops
skill in practicing rational therapeutics. Core attitudes
include attitudes about what constitutes valid information,
what kind of information is likely to be in error and what
new information must be continuously acquired from
reliable sources.
Based on the learning objectives as formulated by
Nierenberg, a questionnaire on core learning objectives
was subsequently developed in the United Kingdom by
Walley [10]. Senior academic clinical pharmacologists who
were active in teaching CP&T in the UK or Ireland assessed
the relative importance of each learning objective as an
element of a core curriculum. This resulted in a list of core
knowledge, skills and attitudes [11] that largely matched
the learning objectives as formulated by Nierenberg [8].
In addition to the approach of Nierenberg and Walley to
defining the core curriculum in CP&T, Orme described two
other approaches to developing a core curriculum for
CP&T [12]. First, based on the WHO concept of an
‘essential drug list‘, he developed two lists of drugs; one list
consisted of approximately 120 essential drugs that students
would be expected to know in detail, and a shorter list
consisted of drugs that students would be expected to be
familiar with but were not required to know in any detail.
This list of essential drugs was then examined by the
Education Subcommittee of the EACPT. The second
approach to defining a core curriculum for CP&T was the
disease-based approach. Three types of disease process
were defined: (1) 67 diseases that were common and that
the student must know how to manage; (2) 158 diseases
that were less common but that students must be able to
diagnose, after which the appropriate therapy could be
found in the literature; (3) 36 diseases that were rare but
that students should be aware of.
Defining a core curriculum for CP&T as presented by
Nierenberg, Walley and Orme is important to defining the
shape and boundary of the discipline and may be helpful as
218 Eur J Clin Pharmacol (2008) 64:217–224part of a medical student's examination. However, in
addition to knowledge, physicians must also have prescrib-
ing skills in order to prescribe rationally.
Therefore, the WHO Action Programme on Essential
Drugs has developed, in collaboration with the University
of Groningen, a manual for undergraduate medical students
on the principles of rational prescribing, the so-called Guide
to Good Prescribing (GGP). This manual provides a
normative model for therapeutic reasoning and prescribing
and provides a six-step guide to the process of rational
prescribing that will be necessary throughout the clinical
career of the medical student (Table 1). All six steps are
based on the core learning objectives, knowledge, skills and
attitudes as formulated by Nierenberg and Walley and on
positive experience in the Netherlands [13, 14].
In addition, the content is based on an observational
study among general practitioners and clinicians in the
Netherlands and on 10 years of experience with pharmaco-
therapy courses for medical students in Dutch medical
faculties and abroad. The GGP has also been reviewed and
examined by a large body of international experts in the
teaching of pharmacotherapy. As reported by De Vries et
al., a short interactive training course in pharmacotherapy,
using the GGP, was evaluated in a controlled study among
219 undergraduate international medical students [15]. This
study indicated that undergraduate students who used the
GGP performed significantly better than students who did
not used the GGP. In addition, students not only remem-
bered how to solve old problems, but they could also apply
their skills to new problems, a so-called transfer effect.
A new framework for the innovation of medical
curricula has been recently introduced, called the Can-
MEDS. The CanMEDS framework describes aspects of
competence related to seven roles of a clinical specialist:
the role of Medical Expert, Communicator, Health Advo-
cate, Collaborator, Manager, Scholar and Professional [16].
Despite the fact that many doctors agree with the
importance of these aspects of competence and that many
countries have already adopted the CanMEDS roles in their
curricula, there is limited information on how these roles
can be applied in an international context and in different
specialities, such as CP&T. Therefore, before clinical
pharmacology as a discipline can adopt the CanMEDS
competencies, the core learning objectives as determined in
the last decades will have to be translated into the
CanMEDS competencies.
In conclusion, in order to improve the competency of
future doctors to prescribe effectively and safely, several
clinical pharmacologists have attempted to determine what
every medical student should master before graduation. A
common feature of all of the competencies formulated is
that all students must acquire a knowledge of the clinical
pharmacology of essential drugs and diseases and must
master prescribing skills in order to become competent in
the rational prescription of drugs.
Therapeutic decision-making
Although, as described previously, there are many essential
therapeutic skills, the final choice of a (drug) treatment for a
patient can be looked upon as a core skill in therapeutics. In
order to find effective ways to teach our future doctors, it is
important to explore how expert doctors arrive at this final
therapeutic decision.
Therapeutic decision-making or therapeutic reasoning is,
together with diagnostic reasoning, an important part of the
process of clinical reasoning. Therapeutic reasoning can be
defined as the step in clinical reasoning that pertains to the
choice of therapy [17]. However, in contrast to the process
of diagnostic reasoning, which has been investigated
extensively, little is known about the process of therapeutic
reasoning. To our knowledge, the first attempt to investi-
gate therapeutic reasoning in real practice was a small
observational study carried out in 1984 in the Netherlands.
The results of this unpublished study constituted the basis
for the development of the WHO six-step model [18]. Over
500 patient consultations by 25 general practitioners and 25
clinical specialists were observed and recorded. In addition,
all doctors were interviewed about their therapeutic
reasoning. Based on this study, it became evident that
doctors generally based their choice of (drug) treatment on
two steps: (1) doctors initially used treatment guidelines or
drug formularies as a starting point; (2) this was followed
by a verification of the suitability of this treatment for the
individual patient and a modification of the choice of
treatment if necessary (for example, in case of co-morbidity
or co-medication). Moreover, it was also observed that the
more experienced physicians knew more standard treat-
ments by heart compared to less experienced physicians.
The first study that described the process of how
therapeutic decisions are made in practice in greater detail
was performed by Denig [19]. By interviewing 169
different general practitioners and 72 hospital physicians,
Table 1 World Health Organisation six-step model of rational
prescribing [18]
Steps Description
Step 1 Define the patient’s problem
Step 2 Specify the therapeutic objective
Step 3a Choose your standard treatment (P-drug)
Step 3b Verify the suitability of your treatment (P-drug)
Step 4 Start the treatment
Step 5 Give information, instructions and warnings
Step 6 Monitor (and stop?) treatment
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factors influence this drug choice [19, 20]. This study
indicated that when a doctor is confronted with a diagnosis –
for example, a patient with both essential hypertension and
a renal disorder – he or she immediately thinks of a number
of pharmacotherapeutic possibilities, referred to as the
‘evoked set’. Depending on the diagnosis, the ‘evoked
set’ consists of 1.7–5 different pharmacotherapeutic options
that are influenced by many factors, such as refresher
courses, the literature, experience and advertisements from
the pharmaceutical industry. The ultimate choice out of the
‘evoked set’ for an individual patient may be either
‘unreasoned’ (routine) or ‘reasoned’ (evaluation of the
different options). However, how the final choice of
treatment is made is still unknown.
In contrast to the scarcity of information available on
therapeutic decision-making, much research has been done
on diagnostic reasoning. When an experienced doctor is
confronted with a patient with certain symptoms and signs,
so-called illness scripts are called up from memory. Illness
scripts contain clinically relevant information on diseases,
their consequences, the context in which diseases develop,
including the personal circumstances, and the experience of
the doctor with previous patients. These scripts are
generated by the frequent solving of diagnostic clinical
problems [21, 22]. Based on recognition, experienced
doctors are able to choose the right script for solving a
specific diagnostic problem efficiently, particularly in
routine cases [23].
In order to verify whether this is the right script for the
individual patient, two types of diagnostic reasoning may
be used – analytical and non-analytical. Analytical reason-
ing is characterised as a slow and relatively time-consuming
process that is carried out consciously and systematically
and, if possible, evidence-based. Less or inexperienced
doctors, such as medical students, mostly use this type of
reasoning, mainly because they do not possess the ability to
call up so-called ‘illness scripts’. In contrast to analytical
reasoning, non-analytical reasoning is carried out rapidly
and subconsciously and is based on experience and pattern
recognition. This type of reasoning is used especially by
experienced doctors. However, when an experienced doctor
is confronted with a complex patient case, he or she will
also use analytical reasoning.
Based on the similarities between therapeutic and
diagnostic reasoning, it is possible to construct a hypothet-
ical model of therapeutic reasoning (Fig. 1)[ 24]. When the
diagnosis has been determined, one or more treatment
scripts will be called up from the memory. In order to
determine the right treatment, an analytical or non-
analytical process, or a combination of both, will start.
This process is similar to the process of diagnostic
reasoning. The chosen treatment and its effect will
contribute to the modification of the existing treatment
scripts or may result in a new treatment script.
However, in order to validate this hypothetical model,
further research should be performed, particularly in terms of
how experienced doctors arrive at their choice of treatment. In
addition, we need to find out how these experienced doctors
differ from less-experienced doctors, such as medical students
and interns. The answers to these questions will provide more
insight into how we should teach therapeutics to students
although it can already be stated that early clinical practice
will support the development of treatment scripts by under-
graduate medical students.
How to teach and learn therapeutics
Gaining knowledge and at the same time applying this
knowledge in practice is essential for learning in general
and,presumably, alsofor the development oftreatment scripts
by medical students. This so-called context-learning seems to
be more effective in many ways than sequential learning, in
which learning and applying knowledge is separated [22, 25,
26]. The positive effect can be explained by theories from
cognitive psychology and medical problem-solving [22, 26–
28]. These theories suggest that the way in which knowledge
is stored in the brain is essential for its recall and application.
Therefore, storing pharmacotherapeutic knowledge in com-
bination with the situation in which this knowledge will be
applied benefits the speed and quality with which the
information is recalled [21, 22, 29].
Context-learning is defined as learning in a setting that is
similar to the setting of the future profession [30]. Context-
learning is based on four basic principles: setting, repeti-
tion, feedback and responsibility [30]. The setting in which
therapeutics is taught or learned should be the same as or as
similar as possible to the setting of the future profession; for
medical students, this is the clinical setting, such as in
primary health care, hospitals or nursing homes. This
clinical setting gives students the opportunity to gain
experience the same way doctors do, allowing them to
Fig. 1 Hypothetical model of therapeutic reasoning [24]
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and to develop illness and treatment scripts [31]. Subse-
quently, students should be given the opportunity to repeat
the therapeutic problem-solving process as much as
possible. Repetition allows students to generate networks
of organised knowledge in the brain. Frequent exposure to
patients and pharmacotherapeutic problems gradually con-
dense these networks into readily accessible therapeutic
scripts. Furthermore, students should also receive feedback
immediately after their performance to assure the conden-
sation of correct therapeutic scripts. Argumentation and
motivational feedback may be a rapid way to reveal the
process of therapeutic thinking and its possible errors.
Finally, students should be responsible for their own
learning. It is the student's own responsibility to repair
any lack of knowledge or skills discovered during their
clinical work and feedback sessions.
Apart from the most extreme form of context-learning,
which is the clinical setting, different variations with lower
levels of concreteness of the context are possible, varying
from role-playing sessions with standardised patients in a
simulated practice setting to the solution of written patient
problems in small working groups and patient demonstra-
tions during lectures. However, there are many ways to
improve the setting, such as by using real case histories
instead of written patient problems or through the use of
video materials, laboratory test results or roentgenograms.
One possible approach to organising a context-learning
programme in therapeutics is described by Vollebregt et al.
[32]. These authors described a context-learning programme
consisting of weekly-organized, role-playing sessions in the
form of consulting hours. The role-playing sessions consist
of three phases: consultation, argumentation and feedback.
First, a ‘student’ doctor must carry out three therapeutic
consultations of 10 min each. Before the start of a
consultation, the doctors are given a written patient case.
Subsequently, the ‘student’ patient and ‘student’ assessor
enter the consultation room, and the doctor has to choose and
prescribe the (drug) treatment interactively with the patient.
The second phase (argumentation) starts immediately after
the consultations. In this phase, the doctor has to substan-
tiate the chosen therapy. Finally, during the third phase, all
students sit together and discuss the various (drug)
treatments and the performance of the doctors, guided by
a clinical pharmacologist.
In addition to teaching therapeutics, assessing students’
therapeutic knowledge and skills is an essential component
of the medical curriculum. In 1990, Miller suggested a
framework for clinical assessment (Fig. 2)[ 33]. According
to this framework, students, residents or physicians must
have knowledge in order to carry out the required
professional functions effectively. Students must also know
how to use the knowledge that they have accumulated. For
example, they must develop the skill that is needed to
acquire information from a variety of human and laboratory
sources, to analyse and interpret data and, finally, to
translate such findings into a rational diagnostic or
therapeutic plan. When this quality is functionally adequate,
it is defined as a competence. Furthermore, students must
not only be able to demonstrate that they know and know
how, but also to show how they do it when confronted with
a patient, which is called performance. Finally, it is
important what a graduate actually does when functioning
independently in clinical practice. According to Miller, this
action component of professional behaviour is the most
difficult to measure.
The Objective Structured Clinical Examination (OSCE)
and structured clinical examinations in general are well-
known and approved methods for assessing competence
and performance [34]. As far as the OSCE is concerned,
this has also been shown to be useful for assessing
therapeutic competence. Nevertheless, it is important that
the manner in which the students are assessed is as similar
as possible to the approach used in teaching them.
In conclusion, based on theories as to how physicians
arrive at their therapeutic decisions, context-learning seems
to be an effective way to teach CP&T to medical students. It
is obvious that the ideal situation, i.e. real practice with real
patients, is not always attainable, but various suboptimal
forms of context-learning and assessment can be applied.
Conclusions and recommendations
In this document, the learning objectives of teaching CP&T
to undergraduate medical students have been described,
with an emphasis on therapeutic decision-making. Based on
Fig. 2 ‘Pyramid’ by Miller as an illustrative framework for discussing
the assessment of clinical skills, competence and performance [33]
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education, we have also discussed context-learning as an
effective approach to teaching medical students how to
prescribe rationally.
Until recently, there were only two groups of people who
were permitted to prescribe drugs – registered medical
practitioners and registered dental practitioners. Since 2006,
some nurses, pharmacists and physician assistants have also
been able to prescribe drugs for medical conditions within
their area of competence [35]. Consequently, given this
increasing number of registered prescribers with different
qualifications, it has become increasingly important to train
prescribers sufficiently in how to choose and prescribe
drugs rationally. In addition, most curricula are changing
from discipline- and subject-based teaching to competence
and integrated or problem-based learning, resulting in less
visibility of CP&T. The importance of teaching CP&T is
further supported by the fact that many graduates still feel
insufficiently prepared to assume prescribing responsibili-
ties after graduation [7]. Furthermore, many hospital
admissions and even deaths are caused by possibly
avoidable medication errors [36].
Clinical pharmacologists should play an important role
in the development of prescribing skills by teaching CP&T
to undergraduate medical students. It is recommended that
they formulate a CP&T context-learning curriculum within
the medical curriculum – of course, in collaboration with
physicians. This curriculum must be based on the final
learning objectives of the CP&T education programme in
which the required level of therapeutic competence of
medical graduates has been determined. In addition, the
curriculum must fulfil the criteria of context-learning, i.e.
gaining knowledge and skills simultaneously in a (simulat-
ed) clinical practice setting. Furthermore, for the sake of
clarity, it is stressed that the CP&T curriculum should be a
visible part of the medical curriculum and that students
must know, from the beginning, the required level of
competence when they graduate. Current medical students
often do not recognise the various CP&T teaching activities
since they are scattered through the medical curriculum.
A draft of a CP&T context-learning curriculum is
presented in Fig. 3. At the start of the curriculum, the
emphasis lies on gaining CP&T knowledge and simulta-
neously learning to apply this knowledge by training skills
in therapeutics. During this phase, little attention is given to
the prescription of drugs in clinical practice.I nt h e
following study years, as CP&T knowledge and therapeutic
skills increase, increased emphasis is given to prescribing in
clinical practice, while the acquisition of knowledge and
skills diminish. An example of a more specific CP&T
curriculum is presented in Box 1.
Inconclusion,effectiveundergraduateteachingofCP&Tis
essential to improve rational prescribing and will immunize
students against factors that may induce irrational prescribing
aftergraduation.Therefore,basedoncurrentknowledgeabout
learning, cognitive psychology and research in therapeutic
teaching, a CP&T curriculum should be a prominent part of
the medical curriculum. The CP&Tcurriculum should also be
linked to postgraduate and continuing education in order to
maintain an optimal competence in rational prescribing after
graduating. Finally, to achieve a CP&T curriculum, allies
should be found because clinical pharmacologists can and
should not work on this alone. Medical students are already
allies; they are interested in clinical pharmacology and really
want to learn how to prescribe drugs rationally. Physicians
should also become allies, since they can provide the clinical
context for teaching and can prevent students from copying
the bad prescribing habits of some of the physicians that train
medical students. Associate clinical pharmacologists must
collectively determine the current state and perspectivesofthe
undergraduate education of CP&T in Europe. To this end, a
European research project, which is organised jointly by the
EACPT and British Pharmacological Society, has recently
been started.
Ultimately, clinical pharmacologists, students and physi-
cians collectively may be able to convince the policy-makers,
suchasthefacultyboards,oftheneedfora CP&Tcurriculum.
Such a joint effort is truly necessary because, unfortunately,
the following words, spoken by Miller in 1990, are, to a great
extent, still valid: “It will not be easy to convince conservative
Medical curriculum
CP&T curriculum
- Knowledge (CP&T)  
- Skills (6-step) 
- Clinical practice (prescribing) 
time
Fig. 3 A design of a clinical
pharmacology and therapeutics
(CP&T) context-learning
curriculum (adapted from HJM
van Rossum)
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conventions that allow clinical impressions to substitute for
systematic accumulation of behavioural evidence, that change
(in teaching, ed.) is in order”.
Box 1. Illustration of a CP&T curriculum
Figure 4 shows the different learning activities and their
mutual relations. The horizontal lines represent the three
learning components: knowledge [upper line: basic phar-
macology, clinical pharmacology, therapeutics (1) and
therapeutics (2)], clinical practice (middle line: video
patients, patient demonstrations, observation of consulta-
tions and prescribing drugs) and skills [lower line:
prescription, drug formulary, prescribing (6-steps) and
CP&T literature]. The vertical lines describe the simulta-
neous use of these three components in order to realise a
context-learning curriculum.
Let us use the example of a clinical pharmacology
department that provides a course of lectures in basic and
clinicalpharmacologyduringthefirstthreeyearsofaclassical
medicalcurriculum.Theaimofthedepartmentistoexpandits
teaching activities and use the context-learning methodology
as much as possible. Therefore, the lectures in basic and
clinical pharmacology must be transformed according to the
criteria of context-learning, i.e. by adding patient cases
(clinical practice) and prescription writing (skills). For
example, the lecture about ‘P-450-dependent oxidation’ is
placed into the clinical context by presenting a video of a
patient case illustrating a drug interaction as the result of a
wrong drug choice (WHO step 3b). The lecture concludes by
discussing the patient case according to the six-step approach,
including how to write a new prescription [18]. The clinical
pharmacology lectures in the second and third year can be
transformed in a similar way by presenting real patients,
followed by lectures on different classes of drugs. Simulta-
neously with the clinical pharmacology lectures, students
must develop a personal drug formulary by, for example,
using an E-learning programme [3]. In the fourth year,
students start on their clinical clerkships. In collaboration
with their clinical colleagues, the clinical pharmacology
department introduces a therapeutic assignment during these
clerkships. Students must observe several consultations by
clinicians in a structured way according to the WHO six-step
approach and discuss these in small groups during therapeu-
tic sessions with a clinical pharmacologist and/or physician.
Concurrently, students must follow a skills training
programme in order to learn how to prescribe rationally
(six steps). During the clinical clerkships in the fifth and
sixth years, prescriptions written by the students are
evaluated by a clinical pharmacologist in collaboration with
a physician and pharmacist during therapeutic sessions.
Finally, students must attend a course on how to evaluate
CP&T literature and how they must apply this knowledge in
practice.
It is evident that in an integrated or problem-based
medical curriculum it will be difficult to organise lectures.
However, an advantage of this type of curriculum is that
teaching is already centred on patient cases. As a result,
clinical pharmacologists can introduce learning tasks with
respect to basic and clinical pharmacology and therapeutics.
In such a curriculum, it will probably be easier to train
students in the six-step approach in small group-teaching
sessions and practice prescribing in a clinical setting.
Obviously, there are various possibilities for context-
learning teaching activities, and the above-mentioned are
just a few examples of these. More detailed information on
how to determine learning objectives for therapeutics and
on methods for teaching and assessing therapeutics can be
found in the WHO Teacher’s Guide to Good Prescribing
[37]. In addition, this guide also provides information on
how to mobilise support for changing and implementing a
CP&T curriculum and how to perform research in this field.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
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CP&T curriculum (example)
video patient. patient demonstr. observ.consultations prescribing drugs
prescription. drug formulary prescribing (6-step) CP&T literature
basic pharm. clin. pharm. therapeutics (1)  therapeutics (2)
year: 1 2,3 4 5,6
Fig. 4 Outline of a CP&T
curriculum
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